Edesa Biotech is trading at $5.06, down 8.33%, with no clear Edesa Biotech-specific announcement identified for August 11, 2026.

  • Its official news page was last updated August 8.
  • The regular session gained 5.34% to $5.52, but after-hours trading reversed sharply.
  • Broader markets were modestly lower but do not clearly explain the reversal; the earlier argenx–Forte Biosciences transaction reflects sector activity, not a direct Edesa catalyst.